The Gross Margin of IX Biopharma Ltd (42C.SI) is 17.59%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-06-30 | 17.59% |
| 2023-06-30 | 39.24% |
| 2022-06-30 | 85.41% |
| 2021-06-30 | -21.89% |
| 2020-06-30 | -59.59% |
| 2019-06-30 | -78.84% |
| 2018-06-30 | -100.41% |
| 2017-06-30 | 35.10% |
| 2016-06-30 | 29.45% |
| 2015-06-30 | 92.30% |